No. | Initial RPR | RPR (3 months after treatment*) | RPR (24 months after treatment*) | CSF/WB (0–8)×106/l | CSF/protein (150–450) mg/l | CSF/VDRL |
1 | 1:64 | 1:8 | 1:16 | 8.1↑ | 860↑ | 1:4 |
2 | 1:16 | 1:4 | 1:4 | 3 | 441 | 1:1 |
3 | 1:32 | 1:8 | 1:8 | 1.1 | 890↑ | 1:2 |
4 | 1:64 | 1:6 | 1:32 | 300↑ | 1860↑ | 1:8 |
5 | 1:32 | 1:4 | 1:8 | 3.8 | 1050↑ | 1:4 |
6 | 1:128 | 1:32 | 1:64 | 8.2↑ | 650↑ | 1:16 |
7 | 1:64 | 1:16 | 1:16 | 9.8↑ | 460↑ | 1:4 |
8 | 1:256 | 1:32 | 1:32 | 5.8 | 580↑ | 1:8 |
9 | 1:64 | 1:8 | 1:8 | 26↑ | 460↑ | 1:4 |
10 | 1:128 | 1:32 | 1:32 | 8.8↑ | 280 | 1:8 |
11 | 1:16 | 1:4 | 1:8 | 9↑ | 540↑ | 1:8 |
12 | 1:128 | 1:16 | 1:16 | 17↑ | 570↑ | 1:4 |
13 | 1:256 | 1:64 | 1:64 | 38↑ | 590↑ | 1:16 |
14 | 1:128 | 1:32 | 1:8 | 2.2 | 430 | 1:2 |
15 | 1:256 | 1:32 | 1:16 | 18.8↑ | 800↑ | 1:4 |
16 | 1:64 | 1:16 | 1:8 | 3.3 | 430 | 1:1 |
17 | 1:16 | 1:4 | 1:4 | 3 | 280 | 1:1 |
↵* Anti-secondary syphilis treatment.